How Selegiline ((-)-Deprenyl) Slows Brain Aging - Image 1

£78.83

Bentham Science Publishers How Selegiline ((-)-Deprenyl) Slows Brain Aging

Name: How Selegiline ((-)-Deprenyl) Slows Brain Aging
Brand: Bentham Science Publishers
Price: 78.83 GBP
Availability: InStock

Depression

This is the most expensive it has ever been. Walk away.

£79 today · previous high £79 · all-time low £70

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 41 days · 41 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 41 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £70 (24 days, 58.5%)

Price range: £70 - £79

Price levels: 2 different prices over 41 days

Description

This book is a reference on Selegiline ((-)-Deprenyl) effects on the brain. Selegiline, described in thousands of research papers, is registered in over 60 countries. At present, more than one hundred preparations containing selegiline circulate in the global market under different brand names. They are widely used in the treatment of Parkinson’s disease, Alzheimer’s disease, major depression and as a geroprotective / anti-aging drug. ((-)-Deprenyl) selegiline, the first selective inhibitor of B-type MAO which, in contrast to the known MAO inhibitors, did not potentiate the effect of tyramine but inhibited it. The compound could be combined with levodopa in Parkinson’s disease without signs of hypertensive reactions. The DATATOP study in the USA revealed that (-)-deprenyl delayed the onset of disability associated with early, otherwise untreated Parkinson’s disease. The age-related decay of the supply of the brain with phenylethylamine (PEA), due to the progressive increase of MAO-B activity in the aging brain, and dopamine, due to the better than average decline of the dopaminergic neuronal activity during the postdevelopmental phase of life, are irresistible biochemical lesions of aging. The speed of deterioration of behavioral performances with the passing of time and longevity depends significantly on the pace of the worsening of these lesions. (-)-Deprenyl, increasing the supply of the brain with PEA and dopamine, counteracts this aging process. Maintenance of male rats from sexual maturity until death on ((-)-deprenyl) delays the age-related loss of the capacity to ejaculate, slows the age-related decline of learning ability and prolongs life. In humans, maintenance from sexual maturity on (-)-deprenyl (1 mg daily) is, for the time being, the most promising prophylactic treatment to fight against the age-related decay of behavioral performances, prolonging life, and preventing or delaying the onset of age-related neurodegenerative diseases such as Parkinson’s and Alzheimer’s. This book is a useful reference for graduate medical students, academic researchers in the field of neuropsychopharmacology, neurophysiology and gerontology and professional research groups in commercial organizations manufacturing selegiline preparations.

Product Specifications

Brand: Bentham Science Publishers
Format: paperback
ASIN: 1608055949
Category: Books > Subjects > Health, Family & Lifestyle > Health Issues > Illnesses & Conditions > Depression
Domain: Amazon UK
Release Date: 31 January 2018
Listed Since: 21 February 2018

Barcode

No barcode data available

Bentham Science Publishers How Selegiline ((-)-Deprenyl) Slows Brain Aging

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Ageing and Dementia: 53 (Journal of Neural Transmission. Supplementa, 53)

Dietary Polyphenols and Neuroprotection

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Senile Dementia of the Alzheimer Type: Early Diagnosis, Neuropathology and Animal Models: 2 (Advances in Applied Neurological Sciences, 2)

Neuroprotection Methods and Protocols: 399 (Methods in Molecular Biology, 399)

Pharmacological Foundations of Parkinson’s Disease: From Mechanisms to Clinical Practice

Neurodegenerative Disorders: Loss of Function Through Gain of Function (Research and Perspectives in Alzheimer's Disease)

Protein Serine/Threonine Kinases in Neurodegenerative Disorders

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Diagnosis and Treatment of Parkinson’s Disease ― State of the Art: 56 (Journal of Neural Transmission. Supplementa, 56)

Neurodegenerative Diseases: 6 (Topics in Medicinal Chemistry, 6)

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)

Presenilins and Alzheimer’s Disease (Research and Perspectives in Alzheimer's Disease)

Malattia di Parkinson e parkinsonismi: La prospettiva delle neuroscienze cognitive

The Benefits of Natural Products for Neurodegenerative Diseases: 12 (Advances in Neurobiology, 12)

Sense and Senility: The Neuropathology of the Aged Human Brain: The Neuropathology of the Aged Human Brain

Neuroprotective Signal Transduction (Contemporary Neuroscience)

Chemical Modulators of Protein Misfolding and Neurodegenerative Disease

APA Publishing Clinical Manual of Geriatric Psychopharmacology

Atypical Parkinsonian Disorders: Clinical and Research Aspects (Current Clinical Neurology)

Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets: 15 (Advances in Neurobiology, 15)

Molecular Imaging of Neurodegenerative Disorders

Molecular Neurosurgery with Targeted Toxins